NM_018027.5:c.3065A>T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_018027.5(FRMD4A):​c.3065A>T​(p.Asn1022Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000919 in 1,586,948 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0052 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00047 ( 4 hom. )

Consequence

FRMD4A
NM_018027.5 missense

Scores

4
14

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 1.43

Publications

1 publications found
Variant links:
Genes affected
FRMD4A (HGNC:25491): (FERM domain containing 4A) This gene encodes a FERM domain-containing protein that regulates epithelial cell polarity. It connects ADP ribosylation factor 6 (ARF6) with the Par protein complex, which regulates the remodeling of adherens junctions and linear actin cable formation during epithelial cell polarization. Polymorphisms in this gene are associated with Alzheimer's disease, and also with nicotine dependence. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
PRPF18 (HGNC:17351): (pre-mRNA processing factor 18) Pre-mRNA splicing occurs in 2 sequential transesterification steps. The protein encoded by this gene is found to be essential for the catalytic step II in pre-mRNA splicing process. It is found in the spliceosome, and contains seven WD repeats, which function in protein-protein interactions. This protein has a sequence similarity to the yeast splicing factor Prp18. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0048624277).
BP6
Variant 10-13651960-T-A is Benign according to our data. Variant chr10-13651960-T-A is described in ClinVar as [Benign]. Clinvar id is 785306.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0052 (790/152054) while in subpopulation AFR AF = 0.018 (748/41468). AF 95% confidence interval is 0.017. There are 7 homozygotes in GnomAd4. There are 403 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FRMD4ANM_018027.5 linkc.3065A>T p.Asn1022Ile missense_variant Exon 24 of 25 ENST00000357447.7 NP_060497.3 Q9P2Q2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FRMD4AENST00000357447.7 linkc.3065A>T p.Asn1022Ile missense_variant Exon 24 of 25 1 NM_018027.5 ENSP00000350032.2 Q9P2Q2

Frequencies

GnomAD3 genomes
AF:
0.00520
AC:
790
AN:
151936
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0181
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000883
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00121
AC:
304
AN:
251468
AF XY:
0.000890
show subpopulations
Gnomad AFR exome
AF:
0.0173
Gnomad AMR exome
AF:
0.000491
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000466
AC:
669
AN:
1434894
Hom.:
4
Cov.:
25
AF XY:
0.000408
AC XY:
292
AN XY:
715712
show subpopulations
African (AFR)
AF:
0.0160
AC:
527
AN:
32892
American (AMR)
AF:
0.000649
AC:
29
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25958
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39564
South Asian (SAS)
AF:
0.0000233
AC:
2
AN:
85686
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5718
European-Non Finnish (NFE)
AF:
0.0000451
AC:
49
AN:
1087526
Other (OTH)
AF:
0.00104
AC:
62
AN:
59432
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00520
AC:
790
AN:
152054
Hom.:
7
Cov.:
32
AF XY:
0.00542
AC XY:
403
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.0180
AC:
748
AN:
41468
American (AMR)
AF:
0.00203
AC:
31
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000883
AC:
6
AN:
67972
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
41
83
124
166
207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000699
Hom.:
0
Bravo
AF:
0.00544
ESP6500AA
AF:
0.0145
AC:
64
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00149
AC:
181
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FRMD4A-related disorder Benign:1
May 01, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.023
T
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.23
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.75
T
MetaRNN
Benign
0.0049
T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
0.55
N
PhyloP100
1.4
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.26
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.023
D
Polyphen
0.12
B
Vest4
0.41
MVP
0.43
MPC
0.41
ClinPred
0.058
T
GERP RS
1.7
Varity_R
0.17
gMVP
0.15
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116500624; hg19: chr10-13693960; API